• Profile
Close

Salivary markers of hepato-metabolic comorbidities in pediatric obesity

Digestive and Liver Diseases Nov 22, 2018

Jacopo T, et al. - In this analysis, the diagnostic role of combined salivary uric acid (UA), glucose and insulin levels to screen noninvasively for metabolic syndrome (MetS) and nonalcoholic fatty liver disease was investigated. Consideration was given to medical, clinical, anthropometric and laboratory data including serum triglyceride, glucose, insulin, HOMA, HDL-cholesterol and UA levels of 23 obese children (15 with [St + ] and 8 without [St–] ultrasonographic hepatic steatosis) and 18 normal weight controls. Findings suggested that salivary testing along with selected anthropometric parameters helps to identify noninvasively obese children with hepatic steatosis and/or MetS components.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay